Mainolfi Nello — SEC insider filings

SEC reporting owner CIK 1821189. 46 insider filings on record with FilingPulse; latest filed 2026-10-01.

Transaction summary — filings shown

Covers all 46 filings on record, filed 2020-08-21 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kymera Therapeutics, Inc. (KYMR)Chief Executive Officer, Director46—78 legs · 752,000 sh · $55,370,406120

Insider filings — Mainolfi Nello

FiledFormIssuerReported transactionsSource
2026-10-014Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 30,000 @ $2.08 · Sale (S): 3,525 @ $111.44 · Sale (S): 5,506 @ $112.42 · Sale (S): 4,876 @ $113.24 · Sale (S): 7,601 @ $114.43 · Sale (S): 8,230 @ $115.40 · +2 moreEDGAR
2026-07-074Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 50,000 @ $2.08 · Sale (S): 50,000 @ $119 · Option exercise (M): 45,559 (derivative) @ $0 · Option exercise (M): 4,441 (derivative) @ $0EDGAR
2026-07-024Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 80,000 @ $2.08 · Sale (S): 1,883 @ $112.80 · Sale (S): 6,626 @ $113.98 · Sale (S): 24,105 @ $114.96 · Sale (S): 44,050 @ $115.69 · Sale (S): 3,336 @ $116.56 · +1 moreEDGAR
2026-04-294Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 30,000 @ $2.08 · Sale (S): 17,005 @ $80.74 · Sale (S): 12,059 @ $81.70 · Sale (S): 936 @ $82.45 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2026-03-044Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 215,000 (derivative) @ $0EDGAR
2026-02-254Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 30,000 @ $2.08 · Sale (S): 19,764 @ $89.78 · Sale (S): 5,434 @ $90.39 · Sale (S): 3,293 @ $91.76 · Sale (S): 1,501 @ $92.81 · Sale (S): 8 @ $93.49 · +1 moreEDGAR
2026-01-064Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 3,118 @ $32.07 · Option exercise (M): 3,118 (derivative) @ $0EDGAR
2025-12-314Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 30,000 @ $2.08 · Sale (S): 23,986 @ $77.95 · Sale (S): 6,014 @ $78.52 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2025-12-174Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 2,595 @ $38.53 · Option exercise (M): 2,595 (derivative) @ $0EDGAR
2025-12-084Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 100,000 @ $2.08 · Sale (S): 100,000 @ $89.17 · Option exercise (M): 100,000 (derivative) @ $0EDGAR
2025-10-294Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 30,000 @ $2.08 · Sale (S): 1,862 @ $59.72 · Sale (S): 24,511 @ $61.02 · Sale (S): 3,627 @ $61.46 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2025-09-164Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 30,000 @ $2.08 · Sale (S): 30,000 @ $49 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2025-06-034Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 30,000 @ $2.08 · Sale (S): 30,000 @ $49 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2025-03-034Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 365,000 (derivative) @ $0EDGAR
2025-01-134Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 10,000 @ $2.08 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2024-07-014Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 18,773 @ $5.33 · Option exercise (M): 18,773 (derivative) @ $0EDGAR
2024-06-204Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 14,413 @ $2.08 · Option exercise (M): 14,413 (derivative) @ $0EDGAR
2024-03-044Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 530,000 (derivative) @ $0EDGAR
2024-01-024Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 9,000 @ $2.08 · Option exercise (M): 9,000 (derivative) @ $0EDGAR
2023-11-064Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 2,368 @ $2.08 · Option exercise (M): 17,632 @ $2.08 · Option exercise (M): 2,368 (derivative) @ $0 · Option exercise (M): 17,632 (derivative) @ $0EDGAR
2023-08-084Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 12,000 @ $2.08 · Option exercise (M): 12,000 (derivative) @ $0EDGAR
2023-03-034Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 450,000 (derivative) @ $0EDGAR
2022-12-084Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 10,000 @ $2.08 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2022-10-174Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 32,056 @ $2.08 · Option exercise (M): 27,676 @ $2.08 · Option exercise (M): 32,056 (derivative) @ $0 · Option exercise (M): 27,676 (derivative) @ $0EDGAR
2022-05-034Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 20,000 @ $2.08 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2022-03-034Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 275,100 (derivative) @ $0EDGAR
2022-01-144Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 10,000 @ $2.08 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2022-01-124Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 22,465 @ $2.08 · Sale (S): 7,485 @ $52.46 · Sale (S): 10,673 @ $53.35 · Sale (S): 4,201 @ $54.40 · Sale (S): 106 @ $54.99 · Option exercise (M): 16,923 @ $2.08 · +11 moreEDGAR
2021-12-164Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 8,000 @ $2.08 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2021-10-124Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 41,544 @ $2.08 · Sale (S): 21,236 @ $55.56 · Sale (S): 9,369 @ $56.82 · Sale (S): 2,078 @ $57.29 · Sale (S): 7,920 @ $59.28 · Sale (S): 670 @ $60.32 · +6 moreEDGAR
2021-08-194Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 12,000 @ $2.08 · Option exercise (M): 12,000 (derivative) @ $0EDGAR
2021-08-054Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 5,669 @ $2.08 · Sale (S): 5,669 @ $60.07 · Option exercise (M): 1,037 @ $2.08 · Sale (S): 1,037 @ $60.03 · Option exercise (M): 5,669 (derivative) @ $0 · Option exercise (M): 1,037 (derivative) @ $0EDGAR
2021-08-024Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 680 @ $2.08 · Sale (S): 680 @ $60 · Option exercise (M): 6,279 @ $2.08 · Sale (S): 6,279 @ $60.07 · Option exercise (M): 23,456 @ $2.08 · Sale (S): 21,632 @ $60.20 · +5 moreEDGAR
2021-07-284Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 9,015 @ $2.08 · Sale (S): 9,015 @ $60.15 · Option exercise (M): 3,864 @ $2.08 · Sale (S): 3,864 @ $60.15 · Option exercise (M): 9,015 (derivative) @ $0 · Option exercise (M): 3,864 (derivative) @ $0EDGAR
2021-07-094Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 48,000 @ $2.08 · Sale (S): 17,230 @ $49.15 · Sale (S): 23,803 @ $49.71 · Sale (S): 6,372 @ $50.96 · Sale (S): 595 @ $51.64 · Option exercise (M): 48,000 (derivative) @ $0EDGAR
2021-06-144Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 40,000 @ $2.08 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2021-06-114Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 23,009 @ $2.08 · Sale (S): 10,103 @ $50.63 · Sale (S): 6,912 @ $51.46 · Sale (S): 5,994 @ $52.53 · Option exercise (M): 23,009 (derivative) @ $0EDGAR
2021-06-094Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 12,724 @ $2.08 · Sale (S): 12,724 @ $50.14 · Option exercise (M): 270 @ $2.08 · Sale (S): 270 @ $50 · Option exercise (M): 5,752 @ $2.08 · Sale (S): 5,752 @ $50.02 · +3 moreEDGAR
2021-05-194Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 15,000 @ $2.08 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2021-05-144Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 8,245 @ $2.08 · Sale (S): 8,245 @ $50.05 · Option exercise (M): 8,245 (derivative) @ $0EDGAR
2021-04-264Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 10,959 @ $2.08 · Sale (S): 10,959 @ $40.26 · Option exercise (M): 680 @ $2.08 · Sale (S): 680 @ $40.01 · Option exercise (M): 2,768 @ $2.08 · Sale (S): 2,768 @ $40.18 · +3 moreEDGAR
2021-04-194Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 4,940 @ $2.08 · Sale (S): 4,940 @ $40.29 · Option exercise (M): 653 @ $2.08 · Sale (S): 653 @ $40.00 · Option exercise (M): 6,000 @ $2.08 · Option exercise (M): 4,940 (derivative) @ $0 · +2 moreEDGAR
2021-04-134Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 15,000 @ $2.08 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2021-04-124Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 9,939 @ $2.08 · Sale (S): 7,616 @ $34.81 · Sale (S): 2,323 @ $35.62 · Option exercise (M): 22,794 @ $2.08 · Sale (S): 19,052 @ $33.58 · Sale (S): 3,742 @ $34.19 · +6 moreEDGAR
2021-03-034Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 375,000 (derivative) @ $0EDGAR
2020-08-214Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 125,399 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1821189 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs